KLRS Q1 2022 Earnings — Kalaris Therapeutics Inc Revenue & Financial Results | Market Cap Arena

KLRSKalaris Therapeutics Inc

$187M

Q1 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$846,000

Operating Income

-$43M

Net Income

-$44M

EPS (Diluted)

$-15.76

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$46M

Free Cash Flow

-$46M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$231M

Total Liabilities

$39M

Stockholders' Equity

$192M

Cash & Equivalents

$100M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$846,000	-$18,000	-4600.0%
Operating Income	-$43M	-$31M	-40.0%
Net Income	-$44M	-$31M	-41.8%